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Abstract 
 
INTRODUCTION: The high incidence of peripheral nerve injury (PNI) in conventional cardiac 
surgery (CCS) is believed to result from mechanical injury during sternotomy and/or retraction 
of the sternum. Minimally invasive cardiac surgery (MICS) is a type of cardiac surgery which 
does not require sternotomy or retraction of the sternum. Since surgery related PNI can lead to 
serious problems for both the patients and care providers, the incidence and details of PNI in 
cardiac surgery needs to be investigated.  
OBJECTIVE: To compare the degree of nerve injury in MICS and CCS using somatosensory 
evoked potential (SSEP) signals. METHODS: 51 participants were prospectively observed 
during surgery for abnormal SSEP signals. SSEP signals were obtained using EPAD®. Also, all 
participants were assessed pre and postoperatively for neurological symptoms involving bilateral 
upper limbs. RESULTS: Full or partial SSEP data were obtained from 41 participants. There 
was a significant difference (P=0.031) in abnormal SSEP signals between the CCS (n=22) and 
MICS (n=19) groups. More abnormal SSEP signals were observed in CCS group compared to 
MICS group. Abnormal SSEP signals were observed independently of sternotomy or sternal 
retraction. CONCLUSIONS: This study suggests that CCS is associated with more 
intraoperative nerve injury when compared with MICS. Future studies should focus on 
preventive and interventional strategies against perioperative nerve injury. 
 
Keywords 
Peripheral Nerve Injury, Minimally Invasive Cardiac Surgery, Conventional Cardiac Surgery, 
SomatoSensory Evoked Potential, Observational Prospective Cohort Study 
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1   Introduction 
1.1 Peripheral Nerve Injuries (PNI) 
Peripheral nerve injury is defined as partial or complete loss of motor or sensory function or 
both. Nerves of interest in this thesis includes the brachial plexus, ulnar nerve, median nerve and 
radial nerve. Since surgery related damage to nerves in the lower extremities is rare1 and not 
related to the main focus of the current study, they will not be described in this thesis.  
 
PNI are a known complication associated with any type of surgery. According to one report,1, 2 
out of 1,541 claims filed for PNI with the American Society of Anesthesiologists, 227 (15%) are 
anesthesia-related. PNI incidence in cardiac surgery ranges from 0.5% to 38%, the most 
prevalent being brachial plexus injury (0.5–38%)3-7 followed by ulnar nerve injury (1.9–24%)4, 8-
10 Other PNIs include saphenous nerve injury, phrenic nerve injury and carpal tunnel syndrome.  
 
The clinical significance of PNI is as follows; with sensory deficit, patients frequently complain 
of a tingling or numb sensation in the upper extremities. This predisposes patients to certain 
injuries, such as burns, falls and/or subsequent bone fractures.  With motor deficits, patients have 
trouble holding objects and have difficulty with activities of daily living. Since both the motor 
and sensory deficits are debilitating and impact patients’ daily lives negatively, research 
regarding this field is of high clinical significance. 
 
The exact mechanisms of injury is unclear and under investigation. However, one study2 
demonstrated the incidence of PNI in noncardiac surgery to be 0.03% while that in cardiac 
surgery was around 15%.3 This high incidence of PNI in cardiac surgery is very concerning to 
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cardiac surgeons and anesthesiologists. Proposed mechanisms for PNIs in cardiac surgery 
include patient’s position, sternotomy, sternal retraction, the use of CardioPulmonary Bypass 
(CPB), systemic inflammation and hypothermia.3, 8, 9, 11, 12  
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1.2 Anatomy of the Upper Extremity 
 
Figure 1. 1 Brachial plexus passing through the clavicle and the first rib13 
 
The Brachial plexus is a group of nerves and consists of the upper root (C5 - 6), the middle root 
(C7) and the lower root (C8 - T1), where C stands for cervical nerve and T stands for thoracic 
nerve. (Figure 1.1)  
 
 
 
 
 
 
 
 
Clavicle 
First rib 
Brachial plexus 
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Figure 1. 2 Innervation of C5 to T1 to the upper extremety13 
 
The upper root innervates the lateral side of the arm/hand and, the middle root innervates the 
mid-portion of the arm/hand and the lower root innervates the medial side of the arm/hand. 
(Figure 1.2) The roots further merge or branch off to form the ulnar nerve, median nerve and 
radial nerve.  
 
Figure 1. 3 Sensory innervation to the hand13 
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The ulnar nerve originates from the lower root (C8 - T1) and innervates the medial side of the 
hand. The sensory innervation is depicted in Figure 1.3. The motor function includes adduction 
of the thumb and flexion of the hand, 4th and 5th digits. In detail, the ulnar nerve innervates the 
following muscles; flexor carpi ulnaris, flexor digitorum profundus, opponens digiti minimi, 
abductor digiti minimi, flexor digiti minimi brevis, the third and fourth lumbrical muscles, dorsal 
interossei, palmar interossei, adductor pollicis, flexor pollicis brevis and palmaris brevis. 
 
The median nerve originates from the upper root (C5 - C6) and the lower root (C8 - T1). The 
sensory innervation is depicted in Figure 1.3. The motor function includes flexion of radial half 
of digits and thumb, abduction and opposition of thumb. In detail, the median nerve innervates 
the following muscles; pronator teres, flexor carpi radialis, palmaris longus, flexor digitorum 
superficialis muscle, flexor digitorum profundus, flexor pollicis longus and pronator quadratus. 
 
The radial nerve originates from C5-T1. The sensory innervation is depicted in Figure 1.3. The 
motor function includes extension of the hand and extension of the fingers. In detail, the radial 
nerve innervates the following muscles; triceps brachii, anconeus, brachioradialis, extensor carpi 
radialis longus, deep branch of the radial nerve, extensor carpi radialis brevis, supinator, 
posterior interosseous nerve, extensor digitorum, extensor digiti minimi, extensor carpi ulnaris, 
abductor pollicis longus, extensor pollicis brevis, extensor pollicis longus and extensor indicis. 
 
1.3 Characteristics and Mechanism of PNI in Cardiac Surgery 
According to one study11 involving 421 patients undergoing CABG, 63 new peripheral nerve 
lesions occurred in 55 patients (13%). In this study, neurological assessment was performed 
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preoperatively and postoperatively on Post-Operative Day (POD) 3 or 4. The same study showed 
an ulnar neuropathy incidence of 1.9–18.3%, a brachial plexus injury rate of 5–10% and a 
phrenic nerve injury rate of 30–70%. All the brachial plexus injuries and 4 out of 5 ulnar 
neuropathies occurred in the left arm. Of the 23 patients who had brachial plexus injury, 21 had 
lower trunk or medial cord injuries. In this study, all the nerve injuries were assessed by 
neurologists, and patients who showed neurological deficits were determined to have nerve 
injury. Most of the injuries were transient, and lasting disability was rare. 
 
Ben-David et al.14 demonstrated that PNI in cardiac surgery is associated with lower root injury 
whereas in noncardiac surgery, upper or middle roots are involved. (See Figure 1.1 for details of 
upper and middle roots) This suggests that PNI in cardiac surgery is frequently caused by 
mechanical injury to the lower root because of its proximity to the sternotomy and the retracted 
structures. The same authors also showed that post–cardiac surgery PNIs are mainly associated 
with sensory deficit, and the motor function is rarely affected, presumably because sensory 
function is more likely to be damaged with mechanical injuries compared to motor function. One 
possible explanation is that sensory nerve responses decrease more and recover less than motor 
nerve responses in the presence of ischemia. This may be due to the difference in diameter 
between two nerve groups and/or faster inexcitability of sensory nerve during ischemia. 15 
 
Unlu et al.5  conducted a retrospective study investigating 575 patients undergoing cardiac 
surgery. All the patients underwent cardiac surgery under moderate hypothermia (30–32℃) and 
were evaluated for symptoms and signs of neurologic deficits related to brachial plexus 
dysfunction prior to surgery. Examination consisted of a detailed past medical history and 
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thorough examination of upper motor and sensory function. Patients were reexamined within 
three days of weaning from the ventilator. When a difference was found, the patients were sent 
for additional examinations, such as electromyogram (EMG) and nerve conduction tests. The 
study found a 0.5% incidence of brachial plexus injury. This study has one of the lowest 
incidences in the literature and the underlying reason would be as follows; in this study, 
postoperative screening was performed by the bedside nurse. It is highly possible that specialists 
would have been able to detect patients with minor or subtle symptoms that the bedside nursed 
might have missed, 
 
One prospective study16 investigating patients undergoing CABG showed that the rate of 
brachial plexus injury was 11% in those receiving ITA harvest compared with 1% in those who 
did not receive it. 
 
Another prospective study7 investigating 1,000 patients undergoing CABG, valve or valve plus 
CABG showed that 27 patients developed PNIs. PNIs were found in 21 of 198 patients who 
underwent internal thoracic artery (ITA) harvest, 4 out of 205 patients, 1 out of 521 patients and 
4 out of 47 patients who underwent valve surgery, CABG and CABG plus valve surgery, 
respectively. The most frequent lesions were at C7-T1 (21 patients), while 6 patients had upper 
trunk lesions (C5,C6). Overall, risk factors included DM, preexisting neuropathy, peripheral 
vascular disease, low BMI, hypothermia, and ITA harvest. Another study17 involving 374 
patients undergoing CABG, valve surgery or aortic surgery showed 6.1% of the patients 
developed 34 new PNIs; 4 with brachial plexus injury (all on the left side), 4 with carpal tunnel 
syndrome and 3 developed worsening preexisting neuropathies. In this study, diabetes mellitus 
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(DM) was found to be the only risk factor.  
 
Jellish et al.18 studied three different types of asymmetric retractors using 60 patients undergoing 
CABG using SomatoSensory Evoked Potential (SSEP) monitoring. They found that one type of 
retractor, the Delacroix-Chevalier, to be associated with an incidence of brachial plexus injury 
based on SSEP change of 5% whereas other types of retractors, the Pittman and Rultract groups, 
had incidences of 25% and 45%, respectively. In addition, the authors found no differences in 
actual incidences of symptomatic PNI (Rultract 1.5%, Delacroix-Chevalier 0.5%, Pittsman 
1.5%) when the postoperative neurological examination was performed by a blinded nurse 
practitioner. This study suggested that the types of retractors may have an impact the 
postoperative incidence of PNI7.  
 
In another study,8, 9 the authors used cadavers to investigate the positions of sternal retraction. 
They found that when the sternal retractor was put in a high position (second intercostal 
position), 7 out of 10 cadavers developed fractures of the first rib while no fractures were 
observed when the sternal retractor was put in a lower position (4th intercostal position). Since 
the brachial plexus passes through the first rib and the clavicle (Figure1.1), mal-positioning of 
the retractor may also result in PNI in cardiac surgery. 
 
Also, in cardiac surgery, all the patients receive an arterial line in the radial artery (Figure 1.4). 
According to the latest report19, the rate of radial nerve injury after radial arterial line insertion is 
0.03%. With this low incidence rate, no research has been done regarding the mechanisms of 
injury. However, direct mechanical injury caused by needle insertion is said to be the most likely 
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etiology. 
1.3.1 Sternotomy and Sternal Retraction  
Sternotomy is a surgical procedure in which a horizontal incision is made on the sternum. After 
sternotomy, the sternum is divided into two pieces and retracted to expose the underlying 
structures, such as the heart and major arteries. (Figure 1.4) 
 
 
 
Figure 1. 4 Sternotomy and retractor. (Left. Sternal retractor Morse®; Right. Sternal retraction)20 
 
One cadaver study12 showed that when the sternal retractor is fully opened, the clavicles are 
pushed into the retroclavicular space, and the first ribs are rotated superiorly. As a result, the 
brachial plexus becomes stretched, causing mechanical injury to the nerve plexus.  
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1.3.2 Sternal Retraction for ITA Harvest 
In CABG, the left internal thoracic artery (ITA) is always used as a graft to the left anterior 
descending artery unless the graft is deemed unusable because of its small caliber or the 
obstructed lumen. During ITA harvest, the sternum needs to be retracted using a sternal retractor 
(Figure 1.5) and the likelihood of mechanical injuries to the brachial plexus is said to be higher 
due to extension of, or the direct injury to, the brachial plexus. 
 
 
Figure 1. 5 Retractor for ITA harvest (Left. Couetil® ITA retractor; Right. Sternal retraction for 
ITA harvest)21 
 
The brachial plexus (Figure 1.1) is a network of nerves that is composed of the cervical nerves 
C5 to C8 and the thoracic nerve T1. Brachial plexus injury is said to occur due to overextension 
with traction force during sternal retraction (indirect injury) and/or compression of the brachial 
plexus between the first rib and the clavicle (direct injury)22.  
 
In one study23, the authors studied 44 patients undergoing CABG using SSEP monitoring. In that 
study, 18% of the patients who had sternal retraction for ITA harvest had brachial plexus 
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symptoms, while only one patient who did not have sternal retraction for ITA harvest had 
neurological symptoms. In the patients who required ITA harvest, SSEP signals did not show 
prolonged latency after removal of the retractors. SSEP showed reduced amplitude in 71% of the 
patients during retraction. The SSEP amplitude change recovered to some extent as soon as the 
retractors were removed but never returned to baseline levels. This study indicates that sternal 
retraction for ITA harvest plays a major role in the etiology of PNI in cardiac surgery. 
 
1.3.3 CPB, Systemic Inflammation  
To date, there is no strong evidence that suggests that the use of CPB is directly associated with 
PNI in cardiac surgery. However, some researchers believe that the high incidence of PNI in 
cardiac surgery cannot be explained solely by the mechanical injuries and that the use of CPB 
and the concomitant systemic inflammation and/or hypothermia may play an important role in 
the etiology of PNI. Since cardiac surgeries of interest in the current study do not require 
hypothermia, it will not be described in detail in this thesis. In one study3, SSEP changes occur 
one hour after the CPB started. The results of this study suggest that systemic inflammation 
resulting from the use of CPB accumulates insults to the nerves over time, resulting in nerve 
injury. 
 
1.3.4 Double Crush Theory 
Upton et al.24 first hypothesized the double crush theory. They postulated that preexisting 
neuropathy makes patients susceptible to carpal tunnel syndrome. They investigated 115 patients 
with carpal tunnel syndrome and found that 70% of them had either generalized neuropathy or 
cervical neuropathy as an underlying pathology. Based on this concept, many researchers started 
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believing that PNI in cardiac surgery does not result from one single trigger but rather a 
combination of multiple insults to the nerves. This may explain the finding that DM is frequently 
identified as a risk factor for PNI, as DM is also known to cause microangiopathy with 
accompanying peripheral nerve injury3, 17, 25, 26.  
 
According to another study27 with 42 patients undergoing cardiac surgery (31 patients had 
CABG, 3 had valve replacement, 2 had combined surgery, 3 underwent redo CABG, and 3 had 
complex surgery involving revision CABG), 11 patients (26%) clinically demonstrated 
postoperative neuropathy. All these patients had pre-existing lesions and there was a direct 
correlation between preoperative deceleration of ulnar nerve conduction and postmedian 
sternotomy neuropathy.  
 
In summary, numerous studies suggest that PNI is common following cardiac surgery, and the 
incidence is much higher than that of general surgery. Regarding the characteristics of PNI, it 
involves predominantly the sensory functions of the lower root nerve distribution in the left 
upper extremity. It is increased by sternal retraction, and specific types of sternal retractors are 
more prone to cause PNI than others, indicating the retraction of the sternum for ITA harvest add 
further insults to vulnerable nerves. Pre-existing neuropathy makes PNI more common as does 
DM. We therefore would expect that MICS (See 1.5 for detail, minimally invasive cardiac 
surgery) would have the lower incidence of PNI than CCS (See 1.4 for detail, conventional  
cardiac surgery), and that during sternal retraction and ITA harvest in CCS, abnormal SSEP 
signals, which indicate nerve injury, should be more commonly observed than at other times in 
either CCS or MICS. 
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1.4 Conventional Cardiac Surgery (CCS) 
 
 
Figure 1. 6 An arterial line in the radial artery and anatomical positions of median and ulnar 
nerves. 
 
CCS in this study is defined as surgery that requires median sternotomy (See Figure 1.4) and 
CPB. Median sternotomy is performed by making an incision on the sternum and dividing the 
sternum into two pieces. The divided sternum is then retracted to expose the underlying 
structures (See Figure 1.5), such as the heart and major vessels. Most commonly, CCS is 
performed with the use of CPB. CPB is composed of two cannulae, i.e. the aortic and venous, the 
membrane oxygenator, the pump and the tubing. The aortic cannula is usually inserted into the 
ascending aorta and the venous cannula is inserted into the right atrium. During CCS, a patient’s 
heart is completely bypassed by the CPB machine to expose intracardiac structures of interest or 
to facilitate the surgical procedures. In the current study, participants undergoing CABG surgery 
or aortic valve replacement (AVR) surgery are included in the CCS group.  
 
Regarding intraoperative positioning, CCS is performed in supine position with bilateral arms 
Arterial line 
Medial nerve 
Ulnar nerve 
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padded and protected with soft towels. 
1.4.1 Coronary Artery Bypass Graft (CABG)  
Most cardiac surgeons perform coronary anastomoses with CPB. The ITA is the most commonly 
used graft for an anastomosis to the left anterior descending artery. The actual surgical procedure 
is as follows: after induction of anesthesia, a triple lumen central line is inserted into the right 
internal jugular vein. Subsequently, the surgery is initiated via median sternotomy. Sternal 
retraction is achieved with a sternal retractor and the left ITA is harvested with ITA retractor 
placed on the sternum. After the graft is optimized for anastomosis, heparin is administered, and 
ascending aorta and right atrial cannula are inserted, and CPB is started. Necessary anastomoses 
are made on the arrested heart, and CPB is weaned. The sternum is closed with metal wires, and 
the patient is brought to the intensive care unit.  
 
1.4.2 Aortic Valve Replacement (AVR) 
After the induction of general anesthesia, median sternotomy is performed, followed by heparin 
administration, cannulation and initiation of CPB. Upon the confirmation of induced asystole, 
the ascending aorta is opened and the aortic valve replaced the aorta is closed and CPB is 
weaned. The sternum is closed with metal wires, and the patient is brought to the intensive care 
unit. 
 
1.5 Minimally Invasive Cardiac Surgery (MICS) 
MICS is defined as surgeries that do not require median sternotomy nor CPB. It is performed 
worldwide for its unique benefits of fast recovery and small surgical incisions. Other advantages 
of MICS may include short length of hospital stay, and less bleeding. In the current study, 
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patients undergoing transcatheter aortic valve implantation (TAVI) surgery or robotic CABG 
surgery are included in this group.  
 
MICS is usually performed in 30-45°lateral position with bilateral arms padded and protected 
with soft towels in the same way as CCS. 
 
1.5.1 Transcatheter Aortic Valve Implantation (TAVI) 
TAVI was first performed in France in 2002 on a patient with aortic stenosis28. TAVI does not 
require sternotomy, retraction of the sternum or CPB. There are two ways to approach the aortic 
valve, i.e. transfemoral and transapical approach. Transfemoral approach is done with incision on 
the groin, and transapical approach is performed with incision in the lateral chest wall.  
 
1.5.2 Robotic CABG29 
Robotic CABG has been performed over the last 20 years in selected institutions. Patient 
selection depends on anatomy, comorbidities, and number of lesions. This procedure does not 
require, sternotomy, retraction of the sternum or CPB. This procedure is performed with a small 
incision in the left lateral chest wall.   
 
1.6 Somatosensory Evoked Potential (SSEP)30, 31 
In SSEP, surface electrodes produce a signal at the site of the peripheral nerve, and another 
electrode at the back of the neck receives the signal. When a neuron gets stimulated, it generates 
an electric signal, which then gets propagated. Recording electrodes measure this compound 
evoked action potential. While electroencephalograms (EEG) record the brains’ spontaneously 
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generated electrical activity over short periods, SSEP is time-locked to a stimulus with a pre-
trigger.  
SSEP provides two types of measurements, i.e. amplitude and latency (figure 1.7). Amplitude is 
defined as the maximum extent of a vibration or oscillation, measured from the lowest point to 
the highest point. Latency is defined as the delay before the actual SSEP waveform is detected by 
the receiver electrode. The normal range of latency and amplitude is reported to be 15.0-16.0 ms 
and 1.0-2.0 microvolt, respectively2, 22, 23.  
Also, SSEP has an embedded filter that removes all the other signals that have different 
amplitudes, such as ECG signals (i.e. SSEP has an amplitude of approximately 1 microvolt while 
ECG has an amplitude of approximately 1 millivolt). It is the gated, repetitive (300/min; 5 Hz) 
summation of individual SSEP signals that enables the very low amplitude SSEP nerve 
conduction impulse to be extracted by filtering the electrical ‘noise’ from other sources including 
myocardial depolarization and 60Hz electrical interference. Stimulation electrodes are placed 
over the course of the desired nerve, with the cathode placed 2 cm proximal to the anode. Skin at 
the scalp EEG electrodes should have an impedance lower than 5,000 ohms. Clinically, the 
amplitude and latency are obtained from each SSEP signal, and because of its high reliability, 
SSEP is frequently used in the OR in patients undergoing spinal cord surgery and surgery for 
scoliosis. Nerve injury commonly results from stretch or direct damage to the nerve. It results in 
the prolongation of latency and/or reduction of amplitude of SSEP signals. According to one 
study32, the sensitivity and specificity of SSEP monitoring in detecting nerve injury 
intraoperatively was reported to be 95% and 100%, respectively, when a cut-off of either 50% 
reduction in amplitude or 10% prolongation of latency was used. Also, it has been reported that 
SSEP monitoring has resulted in a 50–60% decrease in postoperative paraplegia in the scoliosis 
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surgery30.  
 
Figure 1. 7 Amplitude and latency 
 
In order to investigate the incidence of PNIs in two types of cardiac surgeries, we designed this 
observational study using a portable SSEP device (EPAD ®). Conventional SSEP monitoring 
requires a dedicated technician and equipment. The total cost of this monitoring ranges from 
$600 to $8503. Recently, an automated SSEP device, EPAD®, which incorporates an automated 
algorithm for signal activation, acquisition, optimization and interpretation, was developed and 
proved to be useful in cardiac surgery2. In the current study, the electrodes are placed bilaterally 
on the median and ulnar nerves (figure 1.8, stimulating electrodes), midline on the fifth cervical 
spine (figure 1.8, receiving electrode) and midline on the forehead (figure 1.8, reference 
electrode). EPAD® has the ability to automatically detect baseline SSEP amplitude and latency, 
and produce SSEP signals at 300 waveforms per minute. This device automatically records 
baseline values as well as intraoperative SSEP waveforms, and its usefulness has been confirmed 
by some reports2. Also, EPAD® automatically generates all the impedance values at the 
electrode attachment sites. The clinical feasibility of the EPAD® may reduce the need for 
expensive SSEP monitoring and allow for routine monitoring during cardiac surgery by the 
anesthetic provider. 
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Figure 1. 8 SSEP signals obtained on an EPAD. 
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1.7 Primary Objectives 
This paper aims to comparatively analyze the cumulative duration of intraoperative abnormal 
SSEP signals, the average of all monitored nerves (a surrogate marker of nerve injury) between 
MICS and CCS. MICS includes robotic CABG surgery and TAVI, while CCS includes open 
CABG and open AVR. Abnormal SSEP is defined as a 50% reduction in amplitude and/or a 
10% prolongation of latency32. 
 
1.8 Secondary Objectives 
1. Sensitivity and specificity of EPAD® device to detect clinically symptomatic participants 
2. To report the relationship between several factors (DM, renal dysfunction, hypertension, and 
preexisting neuropathy) and abnormal SSEP/neuropathy.  
3. to investigate the relationship between PNI detected through SSEP and the intraoperative 
events, such as sternotomy, the initiation of CPB and ITA harvest. 
 
1.9 Rationale and Hypothesis 
As mentioned in the introduction, PNIs related to surgery can lead to significant medico-legal 
issues as well as functional inconvenience to patients, and a great deal of research has been done 
in this field in general surgery and CCS. However, no data exists regarding PNIs in MICS. Since 
MICS does not require sternotomy, sternal retraction and CPB, we hypothesized that the degree 
of nerve injury is less in MICS compared with CCS. In this study, we will look at the incidence 
of PNIs in MICS compared to CCS using a surrogate marker, i.e. abnormal SSEP signals as an 
indication of intraoperative nerve injury (primary outcome). Also, the relationship between 
intraoperative nerve injuries detected through SSEP and the intraoperative events, such as 
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sternotomy, the initiation of CPB and ITA harvest, has not been researched. Newly developed 
MICS can be used as a control for comparison to sternotomy and the use of CPB. In this study, 
we will investigate the correlation of intraoperative abnormal SSEP signals and intraoperative 
events (secondary outcome). Lastly, we will perform multiple regression analysis to investigate 
the relationship between several predisposing factors and the intraoperative PNI (secondary 
outcome).  
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2   Methodology 
2.1 Study Design 
This is a single-center, prospective observational cohort study with a planned enrollment of 100 
adult cardiac surgery patients, investigating the association between type of cardiac surgery and 
intraoperative nerve injury. The study participants, who underwent either CCS or MICS were 
monitored by an automated SSEP device (EPAD®) to quantify the burden of intraoperative 
peripheral nerve injury (primary outcome) and were followed up in the postoperative period to 
identify clinically apparent new-onset neurological injury (secondary outcomes). 
 
2.2 Setting 
The study was conducted at University Hospital, London Health Sciences Centre, which has 
approximately 1400 cardiac surgery cases annually. Recruitment started in November 2017 and 
was undertaken by the principal investigator. I obtained approval from the Western University 
Health Science Research Ethics Board. The trial was registered into the public domain on 
clinicaltrials.gov (NCT#03422107).  
 
2.3 Participants 
2.3.1 Recruitment 
The day before surgery, the operating room scheduling list is reviewed, and potential study 
candidates are screened. Recruitment takes place in the surgical preparation room adjacent to the 
operating room prior to surgery. The participants who meet the eligibility criteria were 
approached and consented.   
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2.3.2 Inclusion and Exclusion Criteria 
All patients 18–90 years of age undergoing cardiac surgery were included in this study. The 
exclusion criteria include any contraindication to SSEP monitoring, which includes skin burns or 
trauma at SSEP electrode sites (due to inability to place the electrodes), lack of written consent, 
emergency surgery, language barriers, fluctuating neurological symptoms, the utilization of 
regional anesthesia (spinal, epidural, nerve block), CABG with radial artery harvest, and 
combined surgeries, such as CABG plus valve surgery. 
 
2.4 Study Procedures 
Patients were assigned to one of two surgical groups dependent on the use of midline sternotomy 
(CCS) or incision on the chest wall with no sternotomy (MICS). No attempt was made to balance 
the groups with regard to DM, BMI, surgeons or other confounders. 
 
2.4.1 Informed Consent 
Informed consent was obtained from each participant in the surgical preparation area prior to 
entering the operating room. It was explained to the participants that the current study is an 
observational study and no action would be taken when abnormal SSEP signals were detected 
intraoperatively. Signed original consent forms were kept in a locked room in a secure facility at 
University Hospital, London, Ontario. 
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2.4.2 Preoperative Data Collection  
After obtaining written informed consent, a brief bilateral upper-limb motor and sensory 
neurological examination was performed in the surgical preparation area as follows. Firstly, 
participant’s baseline characteristics including a past medical history of: hypertension, diabetes 
mellitus, end-stage renal dysfunction and pre-existing neuropathy, was obtained from the 
participant or the electronic chart. Pre-existing neuropathy here is defined as the presence of 
symptoms at interview, such as tingling and/or numbness in the hands. End-stage renal 
dysfunction is defined as dialysis dependent renal failure. Following this preoperative 
assessment, the examiner performs a cold sensation test using a bag of ice placed on the median 
and the ulnar nerve areas bilaterally. For this test, the area above the clavicle is used as a 
reference point. If the participant is unable to feel the cold as much as the reference point, it is 
described as partial loss, and if the cold sensation is completely lost, it is described as absent. 
Finally, motor function was assessed using manual muscle testing on a scale of 0 – 5 (See 
appendix). 5 = normal strength, 4 = mild weakness (weakly or briefly able to overcome examiner 
resistance), 3 = able to support the limb against resistance but unable to overcome examiner 
resistance, 2 = can move the limb, but unable to lift against gravity, 1 = flicker but no movement, 
and 0 = no movement. The motor function of the ulnar nerve is assessed by asking the participant 
to adduct the thumb and flex the hand, that of the median nerve is assessed by asking the 
participant to flex the hand, abduct and oppose the thumb. The motor function of the radial nerve 
is assessed by asking the participant to extend the hand and the fingers. 
 
All the patients received adequate padding at the elbows to protect ulnar nerves and meticulous 
attention was paid to the arm positioning prior to surgery by the attending anesthesiologists as 
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well as nursing staff. Standard padding in the OR includes soft pads, sponges or towels placed on 
the vulnerable anatomical structures, such as the elbow, arm, hand, and shoulder. CABG, AVR 
and TAVI were performed in the supine position and robotic CABG was performed in the 30-
45°lateral position. 
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2.4.3 Intraoperative Data Collection 
 
Variables Definition Type of variables Source of information 
Diabetes Mellitus Taking oral medication or Insulin Dichotomous variables 
(yes or no) 
Participant’s chart 
Hypertension Taking oral medication Dichotomous variables 
(yes or no) 
Participant’s chart 
End stage renal dysfunction Dialysis dependent Dichotomous variables 
(yes or no) 
Participant’s chart 
Pre-existing neuropathy Tingling/numbness or motor 
dysfunction at baseline 
Dichotomous variables 
(yes or no) 
Preoperative 
neurological assessment 
Duration of surgery Time from skin incision to skin 
closure 
Continuous variables 
(minutes) 
Participant’s chart 
Use of CPB Cardiopulmonary bypass used 
during surgery 
Dichotomous variables 
(yes or no) 
Participant’s chart 
Table 2 Summary of relevant variables collected intraoperatively 
 
Stimulator electrodes were put on the bilateral median and ulnar nerves, and receiver electrodes 
were placed on the back of the neck (fifth cervical spine level, C5). During central line insertion, 
baseline SSEP values are obtained. The data monitored during the study include the amplitude 
and latency. In the current study, all the artifacts are included in the final analyses because 
artifacts are difficult to identify, and inconsistently observed both in CCS group and MICS 
group. All the data collected were recorded on the paper data collection sheets and in Redcap. 
Due to the observational nature of this study, no actions, i.e. change the participant’s positioning 
or modification in surgical techniques, were taken when abnormal SSEP signals were observed.  
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2.4.3.1 The Cumulative Duration of Abnormal SSEP Signals 
This is the primary outcome. Abnormal SSEP signals are defined as at least 50% reduction in 
amplitude and/or 10% prolongation in latency. The EPAD® device has an auto-analysis 
algorithm that detects these abnormalities and generates a detailed report including the raw data 
and processed data, such as baseline SSEP amplitude and latency. The total duration of abnormal 
SSEP signals is the sum of all the durations when abnormal SSEP signals are observed. All the 
calculations are performed on Microsoft Excel using a consistent calculation method to avoid 
measurement error. 
 
2.4.3.2 Timing of Abnormal SSEP Signals 
The principal investigator remains in the operating room and tracks intraoperative events, such as 
sternal retraction for ITA harvest and the initiation and termination of CPB in CABG and AVR, 
valve deployment in TAVI and ITA harvest in Robotic CABG. This is recorded and subsequently 
integrated into the SSEP data. 
 
2.4.4 Postoperative Data Collection 
Follow-up occurred from day 0 to day 5 and consisted of the same neurological exam performed 
preoperatively including sensory and motor testing, where possible, the assessor was blinded to 
the intraoperative SSEP results.  Positive PNI findings were documented and also communicated 
to the surgical team for further follow-up.  
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2.5 Sample Size 
2.5.1 Primary Outcome 
The duration of abnormal SSEP signals, the average of all the monitored nerves, is the primary 
outcome in the current study. We performed a sample size calculation using data obtained from 
our pilot study. We used a mean of 40 minutes duration of abnormal SSEP signals with a 
standard deviation of 20 minutes. With the α = 0.05, Power (1-β) = 0.9, and an allocation ratio = 
1:1. Figure 2 below shows that sample size of 100 and a mean difference of 15 minutes between 
the two groups would provide 95% power to detect a difference.  
 
 
STATA command: power twomeans 40 (10 (1) 30), sd(20) n(100) graph 
 
Figure 2 The result of power analysis performed on STATA 
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2.5.2 Secondary Outcomes 
Secondary outcome 1, sensitivity and specificity of EPAD® to detect PNI is calculated using a 
2x2 table. Sensitivity = TP/TP+FN, Specificity = TN/TN+FP, where TP: true positive, FN: false 
negative, TN: true negative, FP: false positive. True positive is defined as participants who have 
clinical symptoms of PNI and intraoperative abnormal SSEP signals. False negative is defined as 
participants who have clinical symptoms but do not have intraoperative abnormal SSEP signals. 
True negative is defined as participants who do not have clinical symptoms of PNI and do not 
have intraoperative abnormal SSEP signals. False positive is defined as participants who do not 
have clinical symptoms but do have intraoperative abnormal SSEP signals. 2. To report the 
relationship between several factors (DM, renal dysfunction, hypertension, and preexisting 
neuropathy) and abnormal SSEP/neuropathy. Therefore, this will be analyzed with multiple 
regression analysis. 
 
2.6 Statistical Analysis 
The demographics include age, gender, height, weight, Body Mass Index (BMI), type of 
procedure, the presence of hypertension, diabetes, history of stroke, history of end stage renal 
disease, history of pre-existing neuropathy, duration of surgery and duration of CPB. Continuous 
variables are analyzed using either student’s t-test if the variable has a normal distribution or 
Mann-Whitney U test if the variable does not have normal distribution. Dichotomous variables 
are analyzed using Chi-square test or Fisher’s exact test. 
 
Intraoperative nerve injury is defined as the presence of abnormal SSEP signals during surgery. 
Postoperative neuropathy is defined as newly developed neuropathy and/or exacerbation of the 
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pre-existing neuropathy compared to baseline.  
 
The primary outcome, the cumulative duration of abnormal SSEP signals, the average of all 
monitored nerves, was analyzed using Student’s t-test if the variable has a normal distribution or 
Mann-Whitney U test if not. When the SSEP data is not obtained from all 4 nerves, the average 
of 1,2, or 3 nerves are calculated depending on the number of nerves which provided 
interpretable data. When a significant difference is observed in baseline characteristics, the 
primary outcome is adjusted using linear regression analysis. 
 
The secondary outcome will be analyzed using multiple regression analysis. The independent 
variable is the cumulative duration of abnormal SSEP signals, the average of all monitored 
nerves. The dependent variables include diabetes, pre-existing PNI, end stage renal failure 
 and hypertension. 
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3   Results 
All the tables and figures in this chapter will be presented at the end of Chapter 4 for clarity.  
 
3.1 Participants  
Over the 6 months period, 51 participants were screened using the operating room scheduling 
lists. Fifty-one participants were approached and consented to participate in the study (Figure 
3.1). Out of the 51 participants, 41 participants provided intraoperative SSEP data while 10 
participants failed to do so because of technical problems with the EPAD® device. 47 
participants received postoperative neurological assessments, and 6 of them demonstrated 
symptoms of peripheral nerve injury. Four participants were discharged at the time of scheduled 
postoperative neurological assessments and failed to complete the assessments. A total of 41 
participants provided complete or partial SSEP data; 36 participants provided SSEP signals from 
all four nerves (39 participants provided SSEP signals from left ulnar, 40 provided right ulnar, 38 
provided left median and 38 provided right median). In 10 participants, complete data sets were 
not obtained due to technical problems of EPAD® device. The most commonly encountered 
technical problems associated with SSEP data collection was detachment of C5 electrode. Other 
problems included displacement of other electrodes, issues with data transfer and hardware 
problems. 
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3.2   Demographics  
Baseline characteristics are comparable between the two groups with regard to gender, height, 
weight, BMI, rates of hypertension, diabetes, history of stroke, history of end stage renal disease, 
history of pre-existing neuropathy (Table 3.1). There is a statistically significant difference 
between the two groups in age, and participants in MICS group are significantly older than those 
in the CCS group. With regards to co-morbidities, 28 participants had a history of hypertension, 
16 diabetes, 1 non-debilitating stroke, 1 end-stage renal disease and 6 pre-existing neuropathies. 
In the current study, there are no statistically significant differences in the rates of co-morbidities. 
A statistically significant difference between the two groups was noted in the duration of surgery, 
the CCS group had a longer duration of surgery compared with MICS group (230±48 v.s. 116±
39 minutes, P<0.001).  
 
Twenty-two participants in CCS group provided baseline SSEP data while 19 participants did in 
the MICS group (Table 3.2). At baseline, CCS and MICS groups demonstrated SSEP latencies 
and amplitudes within normal limits except for the right median nerve. The latency of the right 
median nerve is statistically significantly longer in CCS group compared with MICS group. 
Other than that, no statistically significant differences were observed between the two groups 
with regard to amplitude and latency.  
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3.3 Outcome Data 
All four nerves were equally affected in the two groups. In the CCS group, 6 of 14 patients 
(44%) who underwent CABG had abnormal SSEP signals during ITA harvest. Overall, the 
abnormal SSEP signals were observed independently of the intraoperative events. In the MICS 
group, abnormal SSEP signals were observed throughout the surgeries independent of 
intraoperative events. 
Six out of 47 participants (4 participants did not complete postoperative neurological 
assessments) developed postoperative neuropathy. Four participants had their left hand affected, 
one had their right hand affected and one was affected bilaterally. Three out of 6 participants had 
a complete set of SSEP data, and the other 3 participants had some or all the data missing 
because of technical problems. Among the 6 participants who showed symptoms of PNI, 4 
participants underwent CABG, 1 had AVR, and the other 1 had TAVI. Only 1 participant 
undergoing CABG had motor dysfunction (left sided motor dysfunction, strength of 2 on a scale 
of 0-5 in the radial region) while none of the other participants had motor deficit symptoms. One 
participant undergoing AVR had tingling/numbness in the right radial nerve distribution. Two 
participant undergoing CABG had left sided numbness/tingling in the ulnar nerve distribution. 
Another participant undergoing CABG had bilateral numbness in the finger tips. The one 
participant undergoing TAVI had left sided loss of sensation in the radial nerve distribution. 
Overall, in the current study, CABG surgery is associated with the highest incidence of PNI after 
surgery based on postoperative neurological assessments, and there is a tendency for left side to 
be affected more frequently compared to the right side. The affected modality was predominantly 
sensory (Table 3.4) 
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3.4 Main Results 
3.4.1 Primary Analysis 
Data are described as mean±SD. 
Using the unadjusted data, the average of the cumulative duration of abnormal SSEP signals was 
higher in CCS group compared to MICS group (1657±2253 seconds vs. 472±481 seconds, P = 
0.031, Figure 4.3); the left ulnar nerve was higher in CCS group compared to MICS group (1842
±2560 seconds vs. 333±753 seconds, P = 0.017); the left median nerve was higher in CCS 
group compared to MICS group (2713±5400 seconds vs. 25±56 seconds, P = 0.027); the right 
ulnar nerve did not show any statistically significant difference 1626±3034  seconds vs. 1180±
1529 seconds, P = 0.575); the right median nerve did not show any statistically significant 
difference (682±1354 seconds vs. 360±706 seconds, P = 0.372).      
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3.4.2 Secondary Analysis 
Table 3. 6 Two by two table for EPAD® in the current study.  
Table 3.6 is on page 68. The sensitivity and specificity of EPAD® to detect clinically 
symptomatic patients is 100% and 11%, respectively. 
 
3.4.2.1 To report the relationship between several factors (DM, renal 
dysfunction, hypertension, and preexisting neuropathy) and abnormal 
SSEP/neuropathy. 
A univariate multiple regression was run to predict the primary outcome (cumulative duration of 
abnormal SSEP signals, the average of all monitored nerves) from age, type of surgery (MICS vs 
CCS), Diabetes, hypertension, Pre-existing neuropathy, end stage renal failure, duration of 
surgery. Firstly, F-test of overall significance indicates whether this multiple linear regression 
model provides a better fit to the data than a model without independent variables. Since P<0.05 
(table 3.7), the null hypothesis that the model with no independent variables fits the data as well 
as our model is rejected.  Secondly, R2=0.428 means our independent variables predict 42.8% of 
the variability of our dependent variable. Lastly, the general form of the equation to predict the 
primary outcome is as follows:  
Cumulative average duration of abnormal SSEP signals= -5760+(46×age) + 
(1388×hypertension) - (211 ×diabetes mellitus) + (561×pre-existing neuropathy) + (1351×end-
stage renal failure) - (290×type of surgery). Only the duration of surgery has the statistically 
significant positive relationship with the primary outcome, P=0.017.  
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3.4.2.2 The Relations between Surgical Procedures/CPB and SSEP Timing 
The association between the intraoperative events and the abnormal SSEP signals was recorded. 
The abnormal SSEP signals were detected independent of intraoperative events in the two 
groups. Overall, 91% and 89% of participants showed abnormal SSEP signals during surgery in 
CCS and MICS groups, respectively. In the CCS group, 73% of the participants had abnormal 
SSEP signals before the initiation of CPB, and 91% of the patients had abnormal SSEP signals 
during or after the initiation of CPB. Specifically, no effect on SSEP signal was seen during 
sternal retraction, ITA harvest or during CPB. In TAVI, there was no association between the 
abnormal SSEP signals and the timing of valve deployment. In Robotic CABG, the abnormal 
SSEP signals were seen regardless of intraoperative events, such as ITA harvest. (Table 3.3) 
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4 General Conclusion  
In this study, I demonstrated that patients undergoing CCS are exposed to more nerve injuries 
compared to those undergoing MICS.  
 
4.1 Discussion 
Previous studies have shown that sternotomy and the retraction of the sternum are responsible for 
higher incidence of PNI in cardiac surgery3 compared to non-cardiac surgery11, and the results of 
the current study are consistent with the previous reports in a sense that surgeries that require 
sternotomy and its retraction have higher rates of PNI compared to surgeries that do not require 
those. However, our current study shows that abnormal SSEP signals are observed independently 
of intraoperative events, such as sternotomy, its retraction or the initiation of CPB. Also, I found 
that only 44% of the patients who underwent CABG had abnormal SSEP signals during ITA 
harvest. This is in contrast to previous studies with have demonstrated that sternal retraction for 
ITA harvest plays a significant role in the etiology of PNIs in CABG 
 
Regarding the relationship between risk factors and abnormal SSEP signals, the current study is 
unable to detect statistically significant risk factors other than the duration of surgery probably 
because of its small sample size.  
 
Interestingly, the vast majority of patients who had abnormal SSEP signals during surgery did 
not display any clinically apparent postoperative symptoms. The presence of false positives, i.e. 
participants who had abnormal SSEP signals without clinical PNI symptoms, might suggest that 
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mere nerve damage is not enough to cause clinical symptoms; rather, additional insults are 
required for symptoms to manifest. Another possibility is that the clinical usability of the 
EPAD® device has been reported in previous studies2, however, sensitivity and specificity of this 
device has never been investigated. Based on the results of the current study, the EPAD® device 
may be more sensitive than conventional SSEP devices. As a result, it is possible that this device 
has a low specificity, and further studies are warranted to investigate its usefulness for its daily 
use in the operating room. At least, a certain level of specificity is required for clinicians to make 
a diagnosis and determine treatment options based on this monitoring tool. In the current study, 
sensitivity and specificity were 100% and 11%, respectively. The built-in automated artifact filter 
of the EPAD® device may have overlooked significant amounts of artifacts. Since EPAD® is a 
newly developed device, the accuracy of the automated filter has not been investigated fully. 
Again, further investigations are warranted to scrutinize this device in the clinical setting. 
 
Four out of 6 participants who had postoperative symptomatic PNI underwent CABG surgery. 
Mechanical injuries, such as sternal retraction and subsequent traction of the brachial plexus, are 
thought to play a major role in the etiology of PNI in this surgery. However, in the current study, 
abnormal SSEP signals were observed throughout this surgical procedure, independent of sternal 
retraction. This implies that injury afflicted by sternal retraction was further compounded by the 
systemic inflammation possibly caused by the use of CPB or the pre-existing susceptibility, such 
as DM, and the combination of at least these events/risk factors might have led to the 
manifestation of PNI symptoms in the vulnerable population. Some pre-existing co-morbidities 
are more prevalent in some groups, i.e. CABG and AVR have more diabetic patients compared to 
Robotic CABG and TAVI because of systemic atherosclerosis. This is one of the confounding 
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factors in this study. Further observational studies using a larger sample size is warranted to 
clarify exactly what types of predisposing factors contribute to the manifestation of postoperative 
PNI symptoms.  
 
In the current study, no statistically significant differences were observed between the two 
groups with regard to amplitude and latency at baseline. This is important because baseline SSEP 
signals provide information regarding pre-existing clinical or subclinical nerve injury. In the 
current study, the baseline SSEP signals were comparable except for the right median nerve. This 
indicates that the rates of patients with pre-existing nerve function were similar between the two 
groups.  In TAVI, the cardiologist places a sheath introducer in the right radial artery, so the 
SSEP electrode for right median nerve was placed a few inches higher compared to other types 
of surgeries in the current study. This might have resulted in the statistically significant 
difference in latency of the right median nerve between the two groups. 
 
Previous studies on PNIs in cardiac surgery have been inconsistent in terms of incidence and 
mechanisms possibly due to the following reasons. Firstly, most patients underreport their PNI 
symptoms on immediate postoperative days. Therefore, detailed history taking and neurological 
assessments are required to capture PNI symptoms post cardiac surgery before symptoms resolve 
spontaneously. This phenomenon was observed in the current study as well, and all the 
participants who had PNIs after cardiac surgery did not inform their surgeons about their 
symptoms. Some participants did not even notice their symptoms and only realized them when 
pertinent questions were asked or neurological examinations were conducted. In the current 
study, we assessed participants on POD 0-5 in order not to miss PNI in the immediate 
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postoperative setting. Secondly, previous studies on cardiac surgery have non-expert assessors, 
such as ICU nurses or nonmedical research assistants, perform neurological examinations or wait 
for the participants to complain of their PNI symptoms.5 It is highly likely that non-experts may 
have missed some cases of PNI. 
 
4.2 Clinical Relevance 
An increasing number of centers have recently started to perform MICS. This trend is based on 
literature that reported the noninferiority of minimally invasive surgery in terms of patient 
prognosis and the absence of recurrence of the original pathologies. MICS is associated with 
early recovery and shorter hospital stay compared to CCS. It has been known that CCS has a PNI 
incidence of around 15%; for MICS, no research has been conducted regarding the incidence of 
PNI. The current study is the first to investigate PNI incidence in MICS in terms of abnormal 
SSEP signals compared with CCS. Although this study is underpowered to compare the 
incidence of clinically apparent postoperative PNI symptoms, our results have demonstrated 
significant differences in incidences of PNI between CCS and MICS using a surrogate marker, 
that is, abnormal SSEP signals. When multiple linear regression was run, no significant 
difference was observed between the two groups in any of the independent variables except for 
the duration of surgery. However, under normal circumstances, MICS has shorter duration of 
surgery compared to CCS. Since the short duration of surgery is one of the advantages of MICS, 
it would be reasonable to say that MICS is associated with less nerve injury as a whole. In 
addition, it is possible that the current study is significantly underpowered to detect risk factors 
for postoperative PNI. Another power analysis needs to be performed to calculate sample size for 
this outcome in the future trials. 
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Also, this study demonstrated that intraoperative PNI occurred throughout the surgery 
independent of sternal retraction or the initiation of CPB. This is in contrast to previous studies 
that PNIs in cardiac surgery are caused mainly by mechanical injuries during sternotomy and 
sternal retraction. The current study suggests that the combination of multiple factors might have 
played a role in the etiology of PNIs in cardiac surgery. These factors include sternal retraction, 
patients’ co-morbidities, such as diabetes and pre-existing neuropathy, and the use of CPB, which 
triggers systemic inflammation that results from the use of foreign body and non-pulsatile blood 
flow33-38. MICS group does not have CPB nor sternal retraction, and this may account for less 
PNI in MICS groups compared to CCS group. Our findings might add more clinical value to the 
indication of MICS in a selected patient population. 
 
4.3 Strengths of the Study 
We performed both preoperative and postoperative neurological assessments. Many previously 
published studies failed to identify an exacerbation of a preexisting neuropathy because they  did 
not perform preoperative neurological assessments7, 14. In the current study, the principal 
investigator assessed participants’ neurological status prior to surgery which permitted the 
detection of pre-existing PNI. Also, most published studies did not perform postoperative 
neurological assessments immediately after surgery14, 16. Since the majority of patients with PNI 
spontaneously resolve with time, a large number of cases might have been missed in those 
studies. In our study, the assessor approached participants within 5 days after surgery and 
performed postoperative neurological assessments to capture symptoms of PNI before they 
resolved spontaneously. 
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Another advantage of the current study is that the assessors are certified anesthesiologists who 
have sufficient training and ability to assess patients’ neurological symptoms. Also, assessors 
who performed postoperative neurological examinations were all blinded to the intraoperative 
SSEP data.  
 
4.4 Limitations of the Study 
There are a few limitations to this study. 
1. No postoperative SSEP monitoring in the ICU was conducted. It has been known that 
symptoms of PNI become apparent a few days or hours after surgery. This means that we 
might have missed onset of PNI that manifested after our postoperative neurological 
assessments. 
 
2. The surrogate marker SSEP was used in our study instead of clinically apparent PNI, which 
have given the incidence of 15%, would render the study significantly underpowered to 
detect differences. In addition, according to one study,4 the sensitivity and specificity of 
SSEP in detecting nerve injury was 95% and 100%, respectively, when the cut-off of either 
50% reduction in amplitude or 10% prolongation of latency was used. This result was used to 
justify the use of SSEP monitoring, as a surrogate for PNI, in the current study. The 
sensitivity and specificity of EPAD® device has not been fully investigated, being a 
relatively new device. The results of the current study suggest that this assumption may not 
be valid.   
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3. In this study, a couple of patients had radial neuropathy after cardiac surgery. Since our 
device was not capable of monitoring the radial nerve (only 4 channels), intraoperative 
insults specifically to the radial nerve were not captured. We included radial nerve 
neuropathy in the postoperative assessments because we assumed that the average 
cumulative duration of all the monitored nerve would reflect the total amount of nerve 
insults. Also, all the participants in the current study received an arterial line in the radial 
artery and all the participants undergoing TAVI received a sheath introducer on the other arm. 
According to the latest report19, the rate of radial nerve injury after radial arterial line 
insertion is 0.03%. Although this incidence is low, we could not rule out arterial line insertion 
as a cause for PNI of the radial nerve in the current study. 
 
4. In the cardiac OR, various types of SSEP signal interference were present, such as electric 
cautery, surgeons leaning on the patient, temporary/permanent pacemakers, and manipulation 
of the transesophageal echocardiogram (TEE) probe. The use of EPAD® device in shoulder 
surgery has been validated39, however, the current study suggests that it may be challenging 
in cardiac OR. Although EPAD has an embedded artifact filter, it is not capable of removing 
all artifacts. The EPAD® device may be more susceptible to artifacts compared to 
conventional SSEP devices because all the electrodes use adhesive pads in the EPAD® 
device compared to needle electrodes used in conventional SSEP monitors. 
 
5. I set our target recruitment at 100, however, I was unable to reach this number for the 
following reasons. Firstly, this study was conducted by a single principal investigator (SF) 
within a period of 1 year. Because of paucity of access to dedicated research time, I was able 
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to recruit 1-2 patient per week on average. As a result, the target number was not met during 
this study period. 
 
4.5 Bias 
Selection bias occurs during identification of the study population. When a study population is 
identified, selection bias takes place when the criteria used to recruit and enroll patients into 
separate study cohorts are inherently different. In the current study, this bias is minimized 
because this is an observational study and outcome variables are unknown at the time of 
recruitment. 
 
Interviewer bias is caused by variations in the way different interviewers collect information 
from participants. In the current study, this bias is minimized in the following way. Only the 
principal investigator performs pre-study interview and preoperative neurological assessments. 
For postoperative neurological assessments, the number of interviewers is limited. Throughout 
the assessment process, interviewers utilize the standardized Redcap data collection sheet for 
their assessment criteria to be consistent.  
 
Outcome misclassification bias results when poorly defined outcomes are used in the analyses. 
The effort to minimize outcome misclassification bias includes the use of an objective and 
validated variable as the primary outcome, and we clearly defined all the outcomes in our 
protocol. In the current study, all the variables used for our analyses are clearly defined in our 
protocol.  
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Confounding occurs when there is a factor that is independently associated with both the 
outcome of interest and the exposure. Multiple regression analysis is performed to control for 
identified confounders. However, unidentified confounders are not controlled due to the 
observational nature of this study. 
 
4.6 Technical Difficulties 
In this study, we encountered quite a few technical difficulties with the EPAD device:  
 
1. As reported by Chui et al.,13 equipment failure frequently occurred at the beginning of the 
study mainly because of poor contact or displacement of the C5 cervical electrode. Since this 
is the only receiving electrode, it is not possible to proceed with the study without a 
functioning C5 electrode. The solution to this problem is to place a new electrode or carefully 
prepare the skin for better adhesion. 
 
2. During TAVI, cardiologists use the right radial artery for the arterial catheter. This practice 
made it impossible to put electrodes on the wrist, so we placed the electrodes a few inches 
higher from the catheter.  
 
3. Various types of artifacts appeared on the screen.  
A. Figure 4.1 shows an interference artifact caused by a certain type of pacemaker. 
According to the manufacturer, EPAD® has the ability to remove artifacts generated by 
most of the pacemakers, but new pacemakers are not registered yet and can cause 
artifacts.  
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Figure 4. 1. Interference artifact. 
 
B. This artifact (Figure 4.2) was due to poor attachment of the receiving electrode with the 
skin. One solution is to prepare the skin with abrasive or lubricant before placing the 
electrode.  
 
 
Figure 4. 2. Poor attachment artifact. 
 
C. When the C5 electrode is displaced, all the waveforms disappear from the screen (Figure 
4.3). The solution is to replace the electrode. 
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Figure 4. 3. No waveforms due to complete electrode detachment. 
 
D. Every time a problem occurs with the device, the data needed to be deleted from the 
tablet. Otherwise, the message below would appear, and the tablet would stop working.  
 
 
Figure 4. 4. An error message that appears when the damaged data is stored.  
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4.7 Final Remarks and Further Direction 
Given the findings of this single center study, the sensitivity and specificity of the EPAD® 
device needs to be investigated in a larger more diverse patient population. This may include 
studies as comparing EPAD® to conventional SSEP devices as the results of the current study 
suggest that the sensitivity of EPAD® device is high but the specificity is low possibly because 
of the captured artifacts.  
 
Further observational studies are needed to identify the exact mechanisms of PNI in cardiac 
surgery. Future studies should investigate only patients at increase risk, such as those with 
diabetes, pre-existing neuropathy, or renal dysfunction. With a larger sample size, the primary 
outcome should be powered to examine the clinical outcome of interest, PNI and its risk factors. 
The current study clarified that the majority of patients get nerve insults during cardiac surgery, 
but not all who have abnormal SSEP signals, as measured by the EPAD® device suffer from 
symptoms of PNI. With an appropriate study design, we will be one step closer to clarifying the 
mechanisms of PNI in cardiac surgery. 
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Tables and Figures of Chapter 3 
 
 
Figure 3. 1 Study participant flowchart for the current study. 
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CCS (n = 22) MICS (n = 19) 
P 
Patient characteristics 
   
Age, y 68 ± 10 82 ± 6.8  <.0001 
Female, n 6  8  0.346 
Height, cm 173 ± 11 166 ± 10 0.057 
Weight, kg 84 ± 17 83 ± 14 0.968 
BMI, m/kg2 28 ± 4 30 ± 5 0.101 
Type of procedure, n 
Coronary bypass grafting 
Aortic valve replacement 
TAVI 
Robotic coronary bypass 
grafting 
14 
8 
0 
0 
0 
0 
15 
4 
 
Hypertension, n 12 16 0.052 
Diabetes, n 7 9 0.352 
History of stroke, n 1 0 1.000 
History of end stage renal 
disease, n 
1 0 
1.000 
History of pre-existing 
neuropathy, n 
3 3 
1.000 
Duration of surgery, min 230 ± 48  116 ± 39  <.0001 
Duration of CPB, min 93 ± 33   NA  NA 
Values are expressed as number (percentage) or mean ± SD when appropriate.  
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NA. Not Applicable; NS. Not Significant 
Table 3. 1 Patient Characteristics. 
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CCS (n=22) MICS (n=19) P  
Amplitude (microV) 
Left ulnar 1.4 ± 0.4 1.3 ± 0.5 
0.675 
Right ulnar 1.2 ± 0.6 1.2 ± 0.6 
0.792 
Left median 1.6 ± 0.6 1.4 ± 0.5 0.295 
Right median  1.6 ± 0.7 1.4 ± 0.6 0.399 
Latency (ms) 
Left ulnar 15.9 ± 1.9 16.0 ± 1.1 0.811 
Right ulnar 16.2 ± 1.9 14.9 ± 3.0 0.098 
Left median 15.4 ± 1.9 15.9 ± 1.4  0.472 
Right median 15.9 ± 1.6 13.6 ± 4.0 0.024 
Table 3. 2 Amplitude and Latency at baseline in CCS and MICS groups. 
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CABG (n=14) 
 Before ITA harvest 
% (n) 
During ITA harvest 
% (n) 
During/after CPB 
% (n) 
Left ulnar nerve 23 (3) 15 (2) 69 (9) 
Left median nerve 17 (2) 17 (2) 42 (5) 
Right ulnar nerve 36 (5) 29 (4) 79 (11) 
Right median nerve 42 (5) 17 (2) 58 (7) 
    
AVR (n=8) 
 Before CPB 
% (n) 
During/after CPB 
% (n) 
 
Left ulnar nerve 25 (2) 38 (3)  
Left median nerve 25 (2) 13 (1)  
Right ulnar nerve 38 (3) 87 (7)  
Right median nerve 25 (2) 38 (3)  
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TAVI (n=15) 
 Before valve 
deployment 
% (n) 
During/after valve 
deployment 
% (n) 
 
Left ulnar nerve 38 (5) 31 (4)  
Left median nerve 23 (3) 8 (1)  
Right ulnar nerve 69 (9) 62 (8)  
Right median nerve 50 (7) 36 (5)  
    
Robotic CABG (n=4) 
 Before ITA harvest 
% (n) 
During/after ITA 
harvest 
% (n) 
 
Left ulnar nerve 0 (0) 50 (2)  
Left median nerve 0 (0) 0 (0)  
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Right ulnar nerve 0 (0) 75 (3)  
Right median nerve 0 (0) 0 (0)  
Table 3. 3 Timing of abnormal SSEP signals 
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Table 3. 4 Breakdown of all six patients who had clinically apparent symptoms of PNIs after 
surgery 
 
 
 
 
 
 
 
 Type of surgery Type of neuropathy Date of assessment (POD) Age HTN DM PEN 
1 AVR Right radial 
tingling/numbness 
3 71 _ _ _ 
2 CABG Left ulnar numbness 4 66 + _ _ 
3 CABG Bilateral numbness in 
finger tips 
3 77 _ _ _ 
4 CABG Left radial motor palsy 3 72 + + _ 
5 CABG Left ulnar tinglings 2 79 + _ _ 
6 TAVI Left radial loss of 
sensation 
1 86 + _ _ 
POD. Post operative day; DM. Diabetes mellitus; HTN. Hypertension; PEN. Pre-existing neuropathy 
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Cumulative duration of abnormal SSEP 
signals 
CCS (n=22)  MICS (n=19) 
P 
Average of all monitored nerves, (sec)  1657±2253 473±481 0.031 
• Left ulnar nerve, (sec) 1843±2560 333±753 0.017 
• Right ulnar nerve, (sec) 1625±3034 1180±1529 0.575 
• Left median nerve, (sec) 2713±5400 25±56 0.038 
• Right median nerve, (sec) 682±1354 360±706 0.372 
Table 3. 5 Cumulative duration of abnormal SSEP signals. Left ulnar, right ulnar, left median, 
right median, and the average of all monitored nerves, unadjusted data. 
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Figure 3. 2 Cumulative duration of abnormal SSEP signals, the average of all monitored nerves, 
using unadjusted data. 
 
 
Table 3. 6 Two by two table for EPAD® in the current study. 
       (N) Abnormal SSEP signals observed 
 
No abnormal SSEP signals observed 
PNI 
symptoms 
3 0 
No PNI 
symptoms 
32 4 
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 df F P 
Regression 7 3.526 .006 
Residual 33   
 R R squared Adjusted R Squared 
Model 0.654 0.428 0.307 
 
Variables Coefficients 
(95% Confidence Interval) 
P value 
Type of surgery 
(MICS vs CCS) 
-290 (-1869, 1289) 0.711 
Diabetes 
-211 (-1346, 925) 0.708 
Pre-existing PNI 
561 (-828, 1951) 0.417 
End stage renal failure 
1351 (-2050, 4754) 0.425 
Hypertension 
1388 (-91, 2867) 0.065 
Age 
46 (-33, 125) 0.242 
Duration of surgery 
16 (3, 29) 0.017 
Table 3. 7 Results of univariate multiple regression analysis 
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Appendix A: List of Abbreviations 
ANOVA Analysis of variance 
AVR  Aortic valve replacement 
BMI  Body Mass Index 
CABG  Coronary artery bypass grafting 
CCS  Conventional cardiac surgery 
CPB  Cardiopulmonary bypass 
EMG  Electromyogram 
HSREB Health science research ethics board 
ITA  Internal thoracic artery 
LAD  Left anterior descending artery 
LM  Left median 
LU  Left ulnar 
RM  Right median 
RU  Right ulnar 
MICS  Minimally invasive cardiac surgery 
OR  Operating room 
PCI  Percutaneous coronary intervention 
POD  Post-operative day 
PNI  Peripheral nerve injury 
SSEP  Somatosensory evoked potential 
TAVI  Transcatheter aortic valve implantation 
RCT  Randomized controlled trial 
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Appendix B: Letter of Information 
Principle 
Investigator 
Satoru Fujii 
 
Researchers: Dr John Murkin, Professor, Department of Anesthesiology, LHSC 
Dr Jason Chui, Department of Anesthesiology, LHSC 
Dr Mackenzie Quantz, Associate Professor, Department of Surgery, LHSC 
Dr Linrui Guo Associate Professor, Department of Surgery, LHSC 
Dr Neil McKenzie, Professor, Department of Surgery, LHSC 
Robert Mayer, Research Associate, Department of Anesthesiology, LHSC 
 
24 Hour 
Contact 
Information: 
 
Please ask for the on-call Anesthesiologist and let them know that you are a study 
participant under Dr. Chui. 
 
Purpose of the 
study:  
The purpose of this letter is to provide information to explain the problem we are 
studying and why we would like you to participate in this study so that you can make 
an informed decision to participate. 
Because you are undergoing cardiac surgery, and we know that cardiac surgery can 
sometimes cause problems with the nerves to your arm and hand, you are invited to 
participate in a study that will evaluate the ability of a non-invasive monitoring device 
to detect whether any of the nerves in your arms are under too much pressure during 
your surgery and whether this device will help reduce such problems.  
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Study 
Summary: 
 
During cardiac surgery when you are under the anesthetic, the surgeon will require 
that your arms or chest are moved in a certain way in order to facilitate the surgery. 
One of the instruments the surgeons need to use is a retractor that pulls on your 
chest and this can interfere with nerves going to your arm. Since you are 
unconscious you cannot tell the surgeon if that position is causing pressure on a 
nerve and this can cause weakness, numbness or tingling in your hand after the 
surgery. This is called a ‘positional neuropraxia’ or peripheral nerve injury (PNI). 
Various studies in cardiac surgery have estimated this can occur in 1 in 100 or as 
many as 1 in 3 patients. Usually these symptoms are mild and do not last more than 
a few weeks but in some patients they may be more severe and long lasting.   
This automated device uses a very tiny electrical signal (SSEP) - which is less strong 
than the tingle you would get from a flashlight battery, to measure how well the 
nerves in your arms are working during your operation and can detect pressure on 
the nerve and gives an alert signal. We want to determine how many patients get 
nerve injury during surgery undergoing two types of surgeries. 
It is expected that in total, we will enroll about 100 patients undergoing cardiac 
surgery for this study. 
 
Study 
procedures:
 
If you agree to 
participate, an 
If you agree to participate, before your surgery and 0 to 5 days afterwards we will do 
an upper limb neurological exam that takes less than 10 minutes. For this we will ask 
you how your arms and hands are feeling and then we will assess the strength in 
your arm by asking you to pull or push your arms and then your hands against the 
examiners arm. We will also ask you to open and close your fingers and will use a 
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additional 10ml 
of blood will be 
taken at the 
same time as 
routine daily 
blood work, 
without the 
need for 
additional 
needle stabs. 
We will also 
collect data 
from your chart 
including your 
diagnosis, age, 
gender, vital 
signs, routine 
laboratory data, 
culture results 
and the result 
of your ICU 
care. 
blunt point (paper clip) to determine whether sensation in your arms and hands is 
similar throughout or whether there are areas of different or missing sensation.  
While you are in the operating room we will put adhesive sensors on each wrist and 
at base of your neck and forehead to measure the function of your arm nerves using 
SSEP during surgery. You will be actively monitored by this device.  
We will also collect data from your chart including your diagnosis, age, gender, vital 
signs, routine laboratory data, and the result of your hospitalization. We will not be 
ordering any additional blood-work or tests for the purposes of this research.  
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Alternatives to 
Study 
Participation 
Currently there are no alternatives for monitoring the nerve functions in your arm 
routinely during anesthesia and cardiac surgery. As our standard of care we always 
employ our best efforts to pad your arms and minimize the amount of surgical 
retractor use but currently we cannot tell whether this is sufficient to prevent nerve 
injury. 
Risks and 
benefits 
associated with 
study:
  
There are no known risks associated with this study since you will NOT be exposed 
to any other additional procedures, tests or treatments and all the sensors are self-
adhesive and non-invasive. This information may potentially benefit patients in the 
future as this information may lead to better medical treatment of patients undergoing 
cardiac surgery 
Conflict of 
Interest 
As a member of the device’s Scientific Advisory Board Dr Murkin has received 
corporate stock options 
Right to ask 
questions: 
If you have any questions concerning this study, contact Dr Satoru Fujii at 519-685-
8500 pager 19147 or Rob Mayer pager18481. If you have any questions about the 
conduct of this study or your rights as a research subject you may contact Dr. David 
Hill, Scientific Director, Lawson Health Research Institute at (519) 667-6649. 
 
Voluntary 
participation: 
 
If you have any 
questions 
concerning this 
Participation in this study is voluntary. You may refuse to participate in this study with 
no effect on your current or future care.  You may also choose to withdraw from this 
study at any time and no further study procedures or data will be collected from you 
or your chart.  
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study, contact 
Dr. Tina Mele, If 
you have any 
questions 
about the 
conduct of this 
study or your 
rights as a 
research 
subject you 
may contact Dr. 
J. Gilbert, VP 
Research and 
Development at 
London Health 
Sciences 
Centre. 
Confidentiality:    Your confidentiality will be respected. Your research records will be stored on a 
computer that is password-protected and not accessible by a network. No personal 
identifying data will be retained or stored. Only your birth year and month and 
hospital chart number will be collected and assigned a research code number. A 
master list with this information will be stored in a separate, locked cabinet. No 
information that discloses your identity will be released or published without your 
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specific consent to the disclosure. However, it is important to note that the original 
signed research consent form will be included in your health record. A copy of the 
Letter of Information will be given to participants of the study to keep. 
Representatives of the research team may require access to your records for the 
purpose of monitoring the study. Representatives of Lawson Quality Assurance (QA)  
Education Program may look at study data for QA purposes. The University of 
Western Ontario Health Sciences Research Ethics Board (HSREB) may contact you 
directly to ask about your participation in the study. Care will be taken to protect 
confidentiality and while we will not voluntarily breach confidentiality, research 
records may well be subject to subpoena and to disclosure by operation of law. 
Because this device is approved for this clinical research study but is not yet licensed 
for sale, Health Canada, and the US Office of Human Research Protection and Food 
and Drug Administration may also look at this study data. 
You do not waive any of your legal rights by signing the Consent Form  
 
 
  70 
CONSENT FORM  
Investigators: Dr. John Murkin, Dr. Satoru Fujii, Dr. Jason Chui, Dr. Mackenzie Quantz, Dr. Linrui Guo, Dr. 
Neil McKenzie, Dr. Roberto Lima, Robert Mayer,. 
Department of Anesthesia and Perioperative Medicine 
London Health Sciences Center 
Schulich School of Medicine 
University of Western Ontario 
 
I have read the Letter of Information, have had the nature of the study explained to me and I agree to 
participate. All questions have been answered to my satisfaction.  I understand I will receive a copy of the 
Letter of Information and signed and dated Consent Form.  
 
  I consent to the use of data collected from me in future studies related to this topic. 
 
  I do not consent to the use of data collected from me in future studies related to this topic. 
 
 
Print Name:   ___________________________________________  
Signature:    ___________________________________________  
Date:    ________________________  
                     YYYY  /     MM   /   DD  
 
I confirm that I have explained the nature of the above investigation to the above-named patient.  
Person Obtaining Informed Consent:  
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Print Name:   ___________________________________________  
Signature:    ___________________________________________  
Date:     ________________________  
                    YYYY  /     MM   /   DD  
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Appendix C: Data Collection Forms 
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